Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
For all of the grant recipients, 50% of the restricted stock units shall vest on the first anniversary of the grant date, and the remaining 50% shall vest quarterly over the subsequent 12 months, subject to the employees' continuous service with Cardlytics through the vesting date. The restricted stock units are subject to the terms and conditions of the 2022 Inducement Plan.
About Cardlytics
Cardlytics (NASDAQ: CDLX) is a commerce media platform, powered by our publishers' first-party purchase data, that makes commerce smarter and more rewarding for everyone. We offer a range of solutions to help advertisers and publishers grow and strengthen customer loyalty. With visibility into approximately half of all card-based transactions in the U.S. and a quarter in the U.K., Cardlytics enables advertisers to engage consumers at scale and drive incremental sales through our industry-leading card-linked offer network. Publisher partners can enhance their platforms with relevant and personalized offers that improve the shopping experience for their customers. Cardlytics also offers identity resolution capabilities through Bridg, which helps convert anonymous shoppers into known and reachable customers. Headquartered in Atlanta, Cardlytics has offices in Menlo Park, Los Angeles, Champaign, New York, and London. Learn more at www.cardlytics.com or follow us on LinkedIn.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
10 minutes ago
- CTV News
Trump threatens to ‘substantially' raise tariffs on Indian goods as it continues to buy Russian oil
Oil tanker trucks are pictured outside an oil refinery operated by Bharat Petroleum Corp. Ltd., in Mumbai, India, on April 4, 2025. (Dhiraj Singh/Bloomberg/Getty Images via CNN Newsource) U.S. President Donald Trump said on Monday that he will 'substantially' raise tariffs on India because it's still buying Russian oil. 'India is not only buying massive amounts of Russian Oil, they are then, for much of the Oil purchased, selling it on the Open Market for big profits,' the president posted on his social media network, Truth Social. 'Because of this, I will be substantially raising the Tariff paid by India to the USA.' But India pushed back, saying it is being unfairly targeted by the United States and European Union for importing oil from Russia. Tariffs are taxes directly paid by importers, though countries exporting goods could indirectly get harmed, as higher prices tend to drive demand down, leading countries to buy more from other countries with lower tariffs or to increase domestic production. Last week, Trump threatened a minimum 25 per cent tariff on goods coming from India, set to take effect at the end of this week. Indian goods are currently subject to a 10 per cent minimum rate. Trump did not specify what new tariff rate goods from India could be charged if it continues to purchase Russian oil. The Indian Ministry of External Affairs said the country began importing from Russia because traditional supplies were diverted to Europe after the start of Russia's war on Ukraine. 'India's imports are meant to ensure predictable and affordable energy costs to the Indian consumer. They are a necessity compelled by (the) global market situation,' a statement posted on social media from the ministry's spokesperson Randhir Jaiswal read. India said both the U.S. and the EU were also 'indulging in trade with Russia.' 'In this background, the targeting of India is unjustified and unreasonable. Like any major economy, India will take all necessary measures to safeguard its national interests and economic security,' the statement said. The Kremlin has also denounced the U.S. plan to raise tariffs on Indian imports. 'We hear many statements that are in fact threats, attempts to force countries to stop their trade relations with Russia,' Kremlin spokesman Dmitry Peskov told reporters Tuesday. 'We do not consider such statements legal. We believe that sovereign countries should have – and do have – the right to choose their own trading partners.' Trump's tariff threat comes as he's upped the pressure on Russia's Vladimir Putin to reach a ceasefire with Ukraine within days, shortening his prior deadline. By Elisabeth Buchwald, Michael Rios, CNN Anna Chernova contributed reporting.
National Post
10 minutes ago
- National Post
Realbotix Deploys AI-Powered Humanoid Robot at Tix4 Kiosk in Las Vegas
Article content A real-world application of AI-powered humanoid robot in customer service role; Article content LAS VEGAS — Realbotix Corp. (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) (' Realbotix ' or the 'Company'), a leader in AI-powered humanoid robotics, is putting its flagship robot, 'Aria,' to work as a customer service representative at the Tix4 kiosk inside the Fashion Show Las Vegas, providing on-site AI-powered customer service, real-time recommendations and assistance on Las Vegas shows, attractions, and local entertainment. Article content Starting August 7th and for a limited engagement, Tix4, the Las Vegas' Strip trip's go-to resource for all things entertainment, will use Aria's advanced conversational AI and emotional intelligence to assist tourists and customers with personalized show and entertainment recommendations, real-time Q&A about local attractions and ticketing and seamless customer support in a dynamic retail environment. With its multilingual capabilities and natural, lifelike interactions, Aria will offer a futuristic and engaging customer experience while helping Tix4 expand its reach to the city's diverse and international audiences. Customers can interact with Aria and ask her questions like 'Aria, what's playing at the Sphere tonight?' or 'Aria, where can I get a reservation at an Italian restaurant for 6 people on Friday night?' or 'Aria, what are the live music options for tonight?' Article content This activation marks the first public-facing deployment of a Realbotix robot in its intended business use case and reflects growing interest from partners in entertainment, hospitality, and retail sectors. With scalable production and modular AI capabilities, Realbotix is positioned to meet growing demand for interactive robotic staff. Article content 'We're taking significant steps in AI-powered humanoid robotics,' said Andrew Kiguel, CEO of Realbotix. 'Deploying Aria in a real-world business setting highlights the readiness of our technology to address practical needs. From concierge desks and airport terminals to healthcare triage and museum tours, we're focused on creating solutions that enhance customer engagement and support businesses in new ways.' Article content Positioned in one of the country's busiest retail and tourism hubs, attracting more than 42 million people per year annually, Realbotix is transforming enterprise operations with the ability to bring lifelike, multilingual AI robots into hotels, airports, hospitals, museums, and beyond. The future of service is here. Article content This commercial deployment represents a major step forward in Realbotix's mission to bring interactive AI robotics into high-traffic, customer-facing environments. Aria's placement highlights the company's progress in transforming prototypes into scalable, revenue-generating products. Article content 'At Tix4, we've always focused on making the Las Vegas entertainment experience more accessible and engaging for visitors,' said Andrew Shack, CEO of Tix4. 'Bringing an AI Robot into our kiosk gives us a futuristic edge. It's not just a novelty, it's a helpful, intelligent guide who enhances how customers explore the city.' Article content We invite members of the media to meet Aria at the Las Vegas Fashion Show Las Vegas at the Tix4 kiosk. Please contact Realbotix@ for more information. Article content About Realbotix Article content Realbotix designs and manufactures AI-powered humanoid robots that improve human experiences through connection, companionship and intelligent interaction. Article content Manufactured in the United States, Realbotix specializes in realistic, customizable robots built for entertainment, customer service, and personal well-being. Our patented AI and robotics technologies enable lifelike expression, motion, and social engagement, making us a category leader in the rapidly evolving field of human-centric robotics. Article content Article content : Product site Article content Article content Article content : Corporate and Investor site Article content Keep up-to-date on Realbotix developments by joining our online communities on Twitter, LinkedIn, and YouTube. Article content About Tix4, Inc. ('Tix4') Article content Since its inception, TIX4 has sold more than 15 million tickets and has decades of experience in providing unparalleled sales and marketing support to the best shows, attractions, and events. TIX4 is dedicated to serving the city's supplementary ticketing needs. Their award-winning, dedicated and experienced ticketing team is committed to helping partners offer a wide array of tickets, from world-class productions to exclusive deals on last-minute bookings. In addition to having direct sales capabilities, TIX4 harnesses the promotional power of digital and traditional media components, including print and out-of-home (OOH). The combination of prime Strip locations, cutting-edge technology, and decades of experience position TIX4 as the optimal choice for engaging and selling to the 40 million annual visitors in Las Vegas. Locations along the world-famous Las Vegas Strip include Fashion Show Las Vegas, Planet Hollywood Resort & Casino, the Showcase Mall, Casino Royale, the Grand Bazaar Shops, and The LINQ Hotel + Experience. Article content Forward-Looking Statements Article content This news release includes certain forward-looking statements as well as management's objectives, strategies, beliefs and intentions. Forward looking statements are frequently identified by such words as 'may', 'will', 'plan', 'expect', 'anticipate', 'estimate', 'intend' and similar words referring to future events and results. Forward-looking statements are based on the current opinions and expectations of management. All forward-looking information is inherently uncertain and subject to a variety of assumptions, risks and uncertainties, as described in more detail in our securities filings available at Actual events or results may differ materially from those projected in the forward-looking statements and we caution against placing undue reliance thereon. We assume no obligation to revise or update these forward-looking statements except as required by applicable law. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Article content Article content Article content Article content Article content Contacts Article content Andrew Kiguel, CEO Email: contact@ Article content Article content
CTV News
10 minutes ago
- CTV News
Pfizer raises annual profit forecast
The Pfizer logo is displayed at the company's headquarters in New York. (AP Photo/Mark Lennihan, File) U.S. drugmaker Pfizer raised its full-year profit forecast on Tuesday after reporting better-than-expected results for the second quarter, boosted by strong demand for its heart disease drug, Vyndaqel, and blood thinner, Eliquis. The drugmaker now expects to earn US$2.90 to $3.10 per share on an adjusted basis in 2025, compared with its previous expectations of $2.80 to $3.00 per share. Shares of the drugmaker rose 2.4 per cent in premarket hours. Pfizer said the new forecast includes an impact of 20 cents per share related to its recent licensing deal with China's 3SBio for experimental cancer treatment. Pfizer's results come at a time when the pharmaceutical industry is under pressure from U.S. President Donald Trump's administration to lower drug prices and is gearing up for 15 per cent tariffs on imports from the European Union. The drugmaker has said it had enough manufacturing capacity across its 10 sites in the United States to mitigate any impact from tariffs and is open to shifting some production to these existing facilities. Investors are also closely monitoring potential disruptions to Pfizer and other companies' vaccine portfolio from policy changes under U.S. Secretary of Health and Human Services, Robert F. Kennedy Jr., a known vaccine skeptic. Vaccines account for about 20 per cent of Pfizer's revenues. On an adjusted basis, Pfizer earned 78 cents per share in the second quarter, compared with analysts' expectations of 58 cents per share, according to LSEG data. (Reporting by Bhanvi Satija in Bengaluru and Michael Erman in New York; Editing by Anil D'Silva)
